Chemical Properties: Molecular Formula: C35H48N10O15 Molecular Weight: 848.81 g/mol Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu CAS Number: 62568-57-4 Purity: 99% (HPLC verified) BBB Permeability: High blood-brain barrier penetration DSIP Research Applications & Mechanisms Primary Research Focus Areas: 1
hospitalization required Maintenance of Remission: Immunomodulators (azathioprine, 6-MP, methotrexate) for steroid-dependent or frequently-relapsing disease Biologic monotherapy or combination therapy (biologic + immunomodulator) for moderate-to-severe disease Step-up or top-down approach based on disease severity, patient risk factors, and prior therapy Biologic Therapy Targets: TNF-: Infliximab (IV), adalimumab (SC), certolizumab pegol (SC) IL-12/23: Ustekinumab (IV induction, SC maintenance) Integrin: Vedolizumab (IV) IL-23: Risankizumab (IV induction, SC maintenance) JAK inhibition: Upadacitinib (oral) Surgical Management Surgery is indicated in approximately 7080% of patients with Crohns disease over their lifetime, per StatPearls
For patients, this means fewer interactions with healthcare systems and less disruption to daily life
"Contact Information Archived December 16, 2008, at the Wayback Machine 1 2 "Griffenhagen Report"
Benefits of BPC-157 & KPV for Healing and Gut Health When your gut and inflammatory pathways are supported at the cellular level, your entire body may begin to function more smoothly and efficiently
Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM
